curriculum vitae p patrick basu, md, mrcp, agaf

Curriculum Vitae

P Patrick Basu, MD, MRCP, AGAF

Personal Information

Address:

Home: 5 Circle Hill Road, Pelham Manor, NY 10803

Office: 5 Station Square, Forest Hills, NY 11375,

718-897-0584 (phone)

718-896-5571 (fax)

Email: [email protected]

Web-site: www.gastrospecialist.com

Citizenship: U.S.A.

Licensure

Available Upon Request

Certification

Diplomat of ABIM in Internal Medicine

Diplomat of ABIM in Gastroenterology

Memberships

American College of Gastroenterological (AGA) Legacy Society

Fellow of the Royal Society of Medicine, London, UK

American Gastroenterological Association (AGA)

American Neurogastroenterology and Motility Society

Member of the Royal College of Physicians London ( UK)

Fellow of the American gastroenterological Association (FAGA)

Association for the Study of Liver Disease (AASLD)

Cohn’s and Colitis Foundation of America

American College of Physicians (ACP)

International Liver Transplant Society

Colon Cancer Foundation of America

American Liver Foundation Advisory Board Member, NY Chapter

National Pancreatic Foundation

Functional Brain-Gut Research

American Society For Gastrointestinal Endoscopy( ASGE)

Hepatitis B organization of America

British Liver Trust

American Medical Association ( AMA)

American college of Gastroenterology (ACG)

Academy of Science, NY

http://www.gastrospecialist.com/

P Patrick Basu CV

2

Hospital Affiliations

Assistant Clinical Professor of Medicine

Columbia University College of Physicians & Surgeons, NY, NY

Division Chief of Gastroenterology and Gastrointestinal Endoscopy

Forest Hills Hospital (North Shore University Hospital at Forest Hills),

Forest Hills, New York

Director of Medical Education & Clinical Research

Forest Hills Hospital (North Shore University Hospital at Forest Hills),

Forest Hills, New York

2007 - Present

Attending Physician, Department of Medicine

Long Island Jewish Medical Center, New Hyde Park, NY

February 2002 – Present

Attending Physician, Department of Medicine

North Shore University Hospital, Manhasset , NY

February 1997 - Present

Attending Physician and Teaching Affiliate, Department of Medicine

New York Hospital Medical Center of Queens, Flushing, NY

September 1996 – Present

Attending Physician and Teaching Affiliate, Department of Medicine

North Shore University Hospital at Forest Hills, Forest Hills, NY

August 1996 – Present

Postdoctoral Training

Sub-Specialty Course Training

November 1999

Endoscopic Ultrasonography, Diagnostic and Therapeutic

Massachusetts General Hospital, Harvard Medical School, Boston, MA

Mentor William Bruges MD

Chief of gastro endoscopy And interventional research

Harvard Medical School , Boston MS

Aug 2001

Mayo Clinic Rochester MN

Endoscopic ultra sound and Interventional Therapeutic Endoscopy

Mentor Christopher Gestoute MD

August 2002

Endoscopic Ultrasonography

P Patrick Basu CV

3

Olympus Corporation, New York, NY

June 2003

Endoscopic Ultrasonography

Academic Medical Center, Amsterdam Netherlands

Mentor Paul Faulken MD

Fellowship:

1993 – 1996

Gastroenterology and Hepatology

Mount Sinai School of Medicine, New York, NY

Residency:

1992 – 1993

Senior Chief Medical Resident and Research Coordinator

New York Downtown Hospital, New York, NY

1990 – 1992

Department of Internal Medicine

Lenox Hill Hospital, New York, NY

1989—1990

Internship in Dept of medicine

Lenox hill hospital

E 76 th st and Park avenue

NY NY

1987– 1989

Bio-Research Assistant,

Harvard Medical School, Mass General Hospital

Boston, MS

Role of Amino Acids in Insulin resistance and Diabetes Type II

1984-1987

Royal Free Hospital London UK

Senior Registrar Dept of Medicine

Prof Neil Macintyre

Hepato Biliary unit

Mentor Dame Sheila Sherlock

1983 – 1984

Resident Medical Advisor – American Embassy, South East Asia ,

Medical licensing M B B S, 1983-1984

Bachelor of Medicine and Bachelor of Surgery

University of Calcutta. Calcutta India,

P Patrick Basu CV

4

1982 – 1983

Senior Resident – Department of Internal Medicine and Cardiology

Indian Postgraduate Medical Education and Research Institute

Calcutta, India

1981 – 1982

Department of Internal Medicine

IPGMER

S.S.K.M. Hospital, Calcutta, India

1980—1981

Compulsory rotatory internship dept of medicine

All Indian Post Graduate Institute

Indian Post Graduate

A J C Bose road , Calcutta India

1975—1980

All Indian institute of Post graduate and research

A J C Bose road ,Calcutta, India,

1974—1975

Pre medical Sir guru das college

Narkel Dangha road calcutta India.

Internship:

1989 – 1990


Honors/Awards

2010

Young Investigators Forum on Functional GI Disorders- FBG (Functional Brain Gut

Research)- Role of Melatonin In Colonic Motility in Irritable Bowel Syndrome – Constipation

A Double Blinded Randomized Placebo control clinical trial ( MIMI C ), Tuscon, Arizona

2010

Abstract No.: SA00385 ( AGD SILVER PRIZE 8,000 rmb ). A new four-day regimen with

dexlansoprazole, moxifloxacin, amoxicillin, nitazoxanide, and doxycycline (DeMAND) in

helicobacter pylori therapy: an open-label randomized clinical trial

2009

Poster of distinction at Digestive Disease Week 2009, Chicago –

―Rifaximin Salvage therapy for Metronidazole resistant Clostridium difficile Colitis”

2009

P Patrick Basu CV

5

Full Bursary award to attend the EASL Special Conference on NAFLD/NASH and Related

Metabolic Disease, taking place in Bologna, Italy, September 24-26, 2009

2009

AGD Silver Prize of RMB 8000 from The Third Ditan International Conference on Infectious

Diseases to be held at Beijing, China from 30 July - 2 Aug , 2009

2009

Presidential Plenary Oral Presentation at the American College of Gastroenterology Meeting,

San Diego, October 2009, A Randomized Open-Label Clinical Trial With Levofloxacin,

Omeprazole, Alinia (Nitazoxanide), And Doxycycline (LOAD) Versus Lansoprazole,

Amoxicillin And Clarithromycin (LAC) In The Treatment Naive Helicobacter pylori

Population

2009

ACG Auxiliary award - The best Scientific paper submitted by a member/fellow of the College,

ACG (American College of Gastroenterology) Oct 2009, A Randomized Open Label Clinical

Trial With Oral Alpha Lipoic Acid And Vitamin E In Non Alcoholic Fatty Liver Disease

2009

Presidents Award for poster – ACG (American College of Gastroenterology) Oct 2009,

Rifaximin Salvage Therapy for Metronidazole-Resistant Clostridium difficile Infection—A

Prospective Pilot Trial

2008

Presidential poster recognition at American College of Gastroenterology Meeting 2008,

Orlando –

―A Retrospective Analysis of the Safety of Outpatient Percutaneous Liver Biopsy in Patients

with Von Willebrand Disease”

1990 – 1991

Outstanding Performance in Residency


ACG/NIH GRANT ACCEPTED 2010

Serum Level Actin Free Gc-globulin: Prognosis of Acute Necrotizing Pancreatitis

Clinical Experience

Gastroenterology, Liver Disease & Nutrition, Internal Medicine


Private Practice, Forest Hills, NY


Private Practice – New York, NY

P Patrick Basu CV

6

Emergency Medicine

August 1996 – July 1998

Attending Physician, E.D.

St. Anthony’s Hospital, Warwick, NY

November 1992 – March 1997


North Shore University Hospital at Forest Hills, Forest Hills, NY

1992-1993


New York Downtown Hospital, New York, NY

1992-1993


Maimonides Medical Center, Brooklyn, NY

Patents

Endoscopic Repair Of Trachea esophageal Fistula (Tissue Graft Sealant

Method. Patent issued.

Endoscopic Placement of Gastric Balloon (EPGB) For Morbid Obesity –

Patent Issued

AUTHOR - TEXT BOOK – 5 CHAPTERS (in press)

Liver Disease and Transplantation: An Algorithmic Approach to Workup and Management of

Common Problems- 2nd

author, Columbia University College of Physicians and Surgeons, NY

Section 8 – Inherited Metabolic Liver Diseases

1. Alpha-1 antitrypsin

2. Wilsons Disease

3. Hereditary Hemachromatosis

Section 9 – Autoimmune and Cholestatic Liver Disease

1. Primary Biliary Cirrhosis

2. Primary Sclerosing Cholangitis

Research

2010

Combination therapy with Pegylated Interferon alfa 2a and Tenofovir in Chronic hepatitisB e

antigen negative naïve population- A randomized open label clinical trial

Assessment of Tissue Tumor Necrosis factor alfa (TTNF–α) as a novel marker for latent Celiac

disease

P Patrick Basu CV

7

HSP-70 as a unique clinical surrogate marker for Hypoxic Hepatopathy

Interferon alfa Antibody (INF alfa AB) as a useful predictive marker of therapy in Chronic

hepatitis C achieving SVR in naïve population

Combination of Interferons (IFa2b plus Consensus Interferons CIFN) in Treatment of Chronic

Hepatitis C - Non responders: COMIT-C Trial – Multicenter Trial

Transdermal Rivastigmine for Treatment of Encephalopathy in Liver Cirrhosis - A Randomized

Placebo Controlled Trial (TREC – trial )

Serum Level Actin Free Gc-globulin: Prognosis of Acute Necrotizing Pancreatitis

Tissue Eotaxin is a precise maker for eosinophilic esophagitis: A double blind RCT trial

2009

A Randomized Open Label Clinical Trial With Pregabalin In The Treatment Regime With

Interferon Therapy For Chronic Hepatitis C

Randomized controlled trial to establish the efficacy of Sorafenib in portal hypertension: A

Multicenter clinical trial

Role of Melatonin In Colonic Motility in Irritable Bowel Syndrome – Constipation A Double

Blinded Randomized Placebo control clinical trial ( MIMI C )

Effect of High-Dose Ribavirin (RBV), Alinia (Nitazoxanide) and Pegylated Interferon (PegIFN)

alfa-2a in attaining Sustained Virologic Response (SVR) in Treatment of Chronic Hepatitis C

(ERAIS-C Trial) in Naïve Genotype 1 Patients

Effects of Sub Lingual Metochlorpropamide in optimizing out patient late elective endoscopy: A

randomized double blind, double dummy placebo control clinical trial

VANISH-C (Viral kinetics with additive effect of Nitazoxanide as Immune Modulator in activating

SVR in Hepatitis C ) study

Romoplostin for thrombocytopenia in HCV

Nitazoxanide in Irritable Bowel Syndrome

Dexlansoprozole( kapidex), Moxafloxacin, Amoxicilline, Nitazoxanide.and Doxycilline (DeMA N

D ) for four days vs Week therapy with Levofloxacin , Omeprazole Nitazoxanide,And Doxicycline

( L O A D ) in naive Helicobacter Pylori Therapy in the community: A Double Blinded

Randomized clinical Pilot study In New York

P Patrick Basu CV

8

REtrospective Analysis of Pan Asian Outcome of Response to Therapy for Hepatitis C - A

Multicenter Study. REPORT-C study – Columbia University, University of Hong Kong & PGI

Chandigarh India

Assessment of von Willebrand disease in patients with liver biopsy, a retrospective study

A Randomized Open-Label Clinical Trial With Levofloxacin, Omeprazole, Alinia (Nitazoxanide),

And Doxycycline (LOAD) Versus Lansoprazole, Amoxicillin And Clarithromycin (LAC) In The

Treatment Naive Helicobacter pylori Population

2008

LEND (Levofloxacin, Esomeprazole, Nitazoxanide and Doxycycline) for the Treatment of

Previously Non-Responsive Helicobacter Pylori

Sequential Nitazoxanide Compared to Sequential Vancomycin as a Salvage Therapy in Recurrent

CDI (Clostridium difficile Infection ) a Prospective Open-Label Randomized Clinical Trial

Rifaximin Salvage Therapy for Metronidazole-Resistant Clostridium difficile Infection—A

Prospective Pilot Trial

Efficacy and Clinical Outcome of oral Rifaximin and Nitazoxanide in IBS ( diarrheal type ). A

placebo control clinical trial

Intraepithelial CD3 and CD 4 as a unique surrogate marker for mucosal immunity in Irritable

Bowel Syndrome

A Randomized Open Label Clinical Trial With Oral Alpha Lipoic Acid And Vitamin E In Non

Alcoholic Fatty Liver Disease

A Randomized Open Label Clinical Trial with Pregabalin in the Treatment Regime with Interferon

Therapy for Chronic Hepatitis C

Prevalence of Restless Leg Syndrome in Patients With Functional Bowel Disease in the

Community

Melatonin in Refractory Gastric Acid related reflux Disease ( MR- GARD ). A randomized

Placebo control clinical trial with Melatonin & Dexlansoprazole

2007

Randomize Double-Blinded Trial with Escalated Dose of Rifaximin, Omeprazole and

Levofloxacin therapy to eradicate H-Pylori. Naïve patients

Pilot Study for the Treatment of Metronidazole Resistant C-Difficile Diarrhea.

P Patrick Basu CV

9

Randomized Double-Blinded Placebo Control Trial: Alum (Aluminum, Magnesium Tricylicate)

Enema for Radiation Proctopathy

2005

EDIT-C (Escalated Dose of Interferon Therapy for Non-Responders of Chronic Hepatitis-C

Population P. Pat Basu, MD & Robert Brown Jr, MD

New York Hospital Queens and New York Presbyterian Medical Center

A Head-to-head trail between Adefovirdipovixil, 10mg used once a day vs. Entacavir .0.5mg once

a day for forty-eight (48) weeks for eantigen negative naïve chronic Hepatitis-B patients.

P. Pat Basu, MD & Natalie Baker, MD

New York Hospital Queens

A precise prognostic index for Acute Pancreastitis (P.A.N.C.R.E.A.S.)

P. Pat Basu, MD

A Pilot study with novel triple therapy to eradicate H-Pylori. Naïve patients with Rifaximin,

Omeprazole and Levofloxain

P. Pat Basu, MD & Frank Palumbo, MD

New York Hospital Queens

2004

TRAGEIC Score, an accurate prognostic clinical index of Acute Liver Failure

P. Pat Basu, MD & Robert Brown Jr, MD

New York Hospital Queens and New York Presbyterian Medical Center

Novel pilot study to eradicate H-pylori naive patient with Rifaximin, Omeprazole and Bismuth

2002

A Randomized Double Blind Trial To Evaluate The Effect and Efficacy Of Esmoprazole over

Lansoprazole On A Continuos 48 Hour pH Monitor With Acid Provoking Meals.

Academic Grant from Astra Zeneca – New York Hospital of Queens

Double Blinded Placebo Controlled Trial ―Anti Fibrotic Effect Of Lecithin-Choline On Non-

Alcoholic Fatty Liver Disease (NAFLD)‖

With Robert Brown, Jr. MD - New York-Presbyterian, New York, NY

1993-1996

―Randomized Multicenter Placebo Control Double Blinded Clinical Trial in Controlling the

Progression of Cirrhosis with Polyenylphosphatidylcholine (P.P.C.).‖

V.A. Medical Center, Bronx, NY

1994 – 1995

Carbohydrate Deficient Transferin (C.D.T.) As An Index Marker For Alcohol Relapse.

P Patrick Basu CV

10


1993 – 1994

―Role of Tissue Inhibitor of Metallopsotrinase (T.I.M.P.) in Abstinent Alcoholics as a Surrogate

Index of Fibrosis.‖


1987 – 1989

Research Role of ―Animo Acids in Hyperlipidemia‖

Ingeborg Laboratories, Merrick, NY

Papers in Preparation

Randomized, Placebo-Controlled Trial of Transdermal Rivastigmine for the Treatment of

Encephalopathy

Effect of Melatonin on Colonic Motility in Patients with Irritable Bowel Syndrome with

Constipation (MIMI-C Trial)

Hepatits C Virus: Clnical Features and Recommendations for Screening, Diagnosis and

Treatment

A Randomized Open-Label Clinical Trial Comparing a Novel Four Drug Regimen LOAD

(Levofloxacin, Omeprazole, Nitazoxinide and Doxycycline) versus LAC (Lansoprazole,

Amoxicillin and Clarithromycin) for the Eradication of Helicobacter pylori

A Randomized Open-Label Trial of Pregablin for the Reduction of Interferon-Induced Adverse

Events in Patients with Chronic Hepatits C Virus.

Effects of Triple Drug Therapy with Nitazoxinide, High-Dose Ribavirin, and Pegylated

Interferon α2a in Patients with Chronic Hepatits C.

Basu, P Patrick; Rayapudi, Krishna; HABIT (H-Homocysteine, A-ALT, B-BMI, I-Insulin

resistance, T-TNF-alpha) score to evaluate severity of Non-Alcoholic Steato Hepatitis

Basu, P Patrick; Rayapudi, Krishna; Kandanati, Vivek; Puran, Ram; Human Heart -Fatty Acid

Binding Protein as an Early Serum Marker for Myocardial Injury, submitted to IRB at Long

Island Jewish Health System

Basu, P Patrick; Rayapudi, Krishna ; Tommy Pacana; Robert Brown Jr; Erectile dysfunction in

NASH patients

Basu, P Patrick; Rayapudi, Krishna ; Tommy Pacana; Robert Brown Jr IL6 levels as a predictor

of SVR in HCV therapy

Basu, P Patrick; Robert Brown Jr ; Rayapudi, Krishna ; Tommy Pacana; Romiplostim for

treatment of Hepatitis C associated thrombocytopenia

Basu, P Patrick; Rayapudi, Krishna ; Brown Jr, Robert; Liver Fatty Acid Binding Protein as a

predictor of reperfusion injury in post Liver transplant patients- being written up for NIH grant

Basu, P Patrick, Rayapudi, Krishna; A Randomized placebo controlled prospective study with

Mesalamine Suppository to control diarrheal symptoms in IBS

Basu, P Patrick, Rayapudi, Krishna; A Randomized trial comparing Baclofen enema with

Glycerin enema in Mast Cell Proctopathy of Irritable Bowel Syndrome

P Patrick Basu CV

11

P Patrick Basu MD, K Rayapudi MD, Tommy Pacana MD, Robert S. Brown Jr; Gc protein in

Pancreatitis

P Patrick Basu MD, K Rayapudi MD, Tommy Pacana MD, Rotigotin in Patients with Restless

Leg Syndrome

Case series on portal biliopathy

Case report on Pancreatic pseudocyst extending into the pericardium

Case report on Fish bone extraction from duodenal mucosa

Publications Prevalence of Restless Legs Syndrome in Patients with Irritable Bowl Syndrome. World

Journal of Gastroentrology. In Press

Entecavir for Treatment of Decompensated Chronic Hepatitis B: A Clinical Update. Expert

Review of Gastroenterology & Hepatology

Therapeutic Advances in Gastroenterology July 2010 vol. 3 no. 4 221-225., Rifaximin therapy

for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial

Gastroenterology and Hepatology, Volume 5, Issue 11, November 2009, Page 801, A

Randomized Open-Label Clinical Trial With Levofloxacin, Omeprazole, Alinia

(Nitazoxanide), And Doxycycline (LOAD) Versus Lansoprazole, Amoxicillin And

Clarithromycin (LAC) In The Treatment Naive Helicobacter pylori Population

―Chlorzoxazone Pharmacokinetics as a Marker of Hepatic Cytochrome P4502E1 in Humans‖

Mt. Sinai School of Medicine and V.A. Medical Center, NY;The American Journal of

Gastroenterology, Vol. 93, No. 11, 1998

―Utility of Carbohydrate-Deficient Transferrin as a Marker of Relapse in Alcoholic Patients‖

Alcohol Clinical and Experimental Research, Vol. 19, No3, 1995: pp 611-616

―Efficacy of a High and Accelerated Dose of Hepatitis B Vaccine in Alcoholic Patients, a

Randomized Clinical

Trial‖;American Journal of Medicine September 1997, Volume 103

―Effectiveness of High Dose Hepatitis B Vaccine in Alcoholic Patients, a Randomized Placebo

Controlled Trial‖

Published as an abstract in Gastroenterology, 1995;108:a1158

―Case Report in Factitious Diarrhea from Ingestion of Aloe‖; Journal of North Shore

University Hospital of Forest Hills, 1996

―Intractable Hiccups from Colonic Intersussuption‖, 1996

Published Abstracts/Poster

P.Patrick Basu, MD, MRCP, Nithya Krishnaswamy, MD, Niraj James Shah, MD, Tamer

Montaser, MD, Chris Tang, MD,PhD and Robert Brown, MD Pan-Asian Variability of

Interleukin 28B (IL28B) Gene Polymorphism and Relationship to Sustained Viral Response

P Patrick Basu CV

12

(SVR) in Chronic Hepatitis C Genotype 1; A Retrospective Study - PANIC TRIAL. June

2011, ILTS. In Press


Montaser, MD, Chris Tang, MD, PhD and Robert Brown, MD Transdermal Rivastigmine for

Treatment of Encephalopathy in Liver Cirrhosis - A Randomized Placebo Controlled Trial

(TREC trial ). June 2011, ILTS. In Press-

P Patrick Basu, N V Krishnaswamy, N James Shah, S Farhat, R S Brown "Serum Retinol

Binding Protein 4 (RBP-4) is a unique surrogate marker of End stage Liver Disease. June, 2011

EASL Monothematic Conference- Liver Fibrogenesis. In Press

P Patrick Basu, Niraj James Shah, Nithya Krishnaswamy, Chris Tang. EFFECT OF

MELATONIN IN FUNCTIONAL HEART BURN--A RANDOMIZED PLACEBO-

CONTROLLED CLINICAL TRIAL. Sept, 2011, Neurogastroentrology & Motility. In Press

P Patrick Basu, Niraj James Shah, Nithya Krishnaswamy, Chris Tang. Effect of Melatonin in

Functional Heart Burn- A Randomized Placebo-Controlled Clinical Trial. Gastroenterology

May 2011, Vol. 140, Issue 5, Supplement 1, Page S-169

P Patrick Basu, Niraj James Shah, Nithya Krishnaswamy, Chris Tang. Comparison of

Nitazoxanide and Vancomycin Taper Regimens as a Salvage Therapy for Patients With

Recurrent Mild to Moderate Clostridium difficile Infection (CDI). Gastroenterology May 2011,

Issue 5, Supplement 1, Page S-325

Patrick Basu, Nithya Krishnaswamy, Niraj James Shah, Chris Tang Serum Retinol Binding

Protein 4 (RBP-4) is a Unique Surrogate Marker of END Stage Liver Disease With

Complications. A Pilot Clinical Trial. Gastroenterology May 2011, Vol. 140, Issue 5,

Supplement 1, Page S-957.

P Patrick Basu, Nithya Krishnaswamy, Niraj James Shah, Sajith J. Foustin, Chris Tang, Robert

S. Brown. Interferon Alfa Antibody (IFN Alfa Ab) as a Useful Predictive Marker of Sustained

Viral Response (SVR) for Therapy in Chronic Hepatitis C. Gastroenterology May 2011, Issue

5, Supplement 1, Page S-911

P Patrick Basu, Niraj James Shah, Nithya Krishnaswamy, Robert S. Brown. Effects of

Interferon Alpha on Parathyroid Gland in Chronic Hepatitis B and C: An Observational Study.

Gastroenterology May 2011, Issue 5, Supplement 1, Page S-970

P Patrick Basu, Niraj James Shah, Nithya Krishnaswamy, Sajith J. Foustin, Chris Tang, Tommy

Pacana, Robert S. Brown

. Pan-Asian Variability of Interleukin 28b (IL28B) Gene

Polymorphism and Relationship to Sustained Viral Response (SVR) in Chronic Hepatitis C

Genotype 1. Gastroenterology May 2011, Issue 5, Supplement 1, Pages S-455-S-456.

P Patrick Basu, Hemanth Hampole, Niraj James Shah, Vinod Mohan, Nithya Krishnaswamy,

P Patrick Basu CV

13

Chris Tang, Tamer Montaser. Effects of Orally Disintegrated Metoclopramide (ODM) in

Optimizing Late Out Patient Endoscopy: A Randomized Double-Blinded Placebo Control

Clinical Trial. Gastrointestinal Endoscopy April 2011, Vol. 73, Issue 4, Supplement, Page

AB40

P Patrick Basu, MD,MRCP, AGAF, N James Shah MD, N V Krishnaswamy MD, Tommy

Pacana MD, J Khemani MD, S Farhat MD, C Tang MD, PhD R S Brown Jr MD .MPH; . Effect

of Vitamin E and Alfa Lipoic Acid In Non-alcoholic fatty liver disease: A randomize placebo

control prospective clinical Trial-V A I N Trial. Journal of Diabetes. 2011 April; Volume 3,

(Supplements1)Pages iv–iv, 11

P.P. Basu, N. Krishnaswamy, N.J. Shah, T. Pacana, C. Tang, S. Foulstin, R.J. Brown. Serum

Retinol Binding Protein 4 as a unique surrogate marker of End stage Liver Disease with

Complications. A Pilot trial. Heptaology International. February 2011, Volume 5, Number 1

P.P. Basu, N.J. Shah, N. Krishnaswamy, S. Foustin, C. Tang, T. Pacana, R.J. Brown. Pan-

Asian Variability of Interleukin 28B (IL28B) Gene Polymorphism and Relationship to

Sustained Viral Response (SVR) in Chronic Hepatitis C. Heptaology International. February

2011, Volume 5, Number 1

P.P. Basu, N. Krishnaswamy, N.J. Shah, T. Pacana, S. Foulstin, C. Tang, R.J. Brown.

Effects

of Interferon Alpha on Parathyroid Gland in Chronic Hepatitis B and C: An Observational

Study. Heptaology International. 2011, Volume 5, Number 1

P.P. Basu, N.J. Shah, N. Krishnaswamy, S. Foustin, C. Tang, T. Pacana, R.J. Brown. Interferon

alfa Antibody A Useful Predictive Marker of Sustained Viral Response (SVR) for Therapy in

Chronic Hepatitis C. Heptaology International. 2011, Volume 5, Number 1

P Patrick Basu, MD,MRCP, AGAF, N James Shah MD, N V Krishnaswamy MD,

Tommy Pacana MD, J Khemani MD, S Farhat MD, C Tang MD, PhD R S Brown Jr MD

.MPH; . Effect of Vitamin E and Alfa Lipoic Acid In Non-alcoholic fatty liver disease: A

randomize placebo control prospective clinical Trial-V A I N Trial. 4th International Congress

on Prediabetes and the Metabolic Syndrome in Madrid, Spain, April 6-9, 2011

The 21st Conference of the Asian Pacific Association for the Study of the Liver

(APASL 2011)17-20 February 2011, QSNCC, Bangkok Thailand. Serum Retinol Binding

Protein 4 as a unique surrogate marker of End stage Liver Disease with Complications. A Pilot

trial


(APASL 2011)17-20 February 2011, QSNCC, Bangkok Thailand. Pan-Asian Variability of

Interleukin 28B (IL28B) Gene Polymorphism and Relationship to Sustained Viral Response

(SVR) in Chronic Hepatitis C


(APASL 2011)17-20 February 2011, QSNCC, Bangkok Thailand. Effects of Interferon Alpha

on Parathyroid Gland in Chronic Hepatitis B and C: An Observational Study


(APASL 2011)17-20 February 2011, QSNCC, Bangkok Thailand. Interferon alfa Antibody

A Useful Predictive Marker of Sustained Viral Response (SVR) for Therapy in Chronic

Hepatitis C

A New Four-day regimen with Dexlansoprazole, Moxifloxacin, Amoxicillin, Nitazoxanide,

and Doxycycline (DeMAND) in Helicobacter Pylori Therapy: An Open-label Randomized

Clinical Trial. American Journal of Gastroentrology. ACG 2010, San Antonio, TX; October

18-20

P Patrick Basu CV

14

Sequential Use of Nitazoxanide(NTZ) as a Salvage Therapy in Patient with Recurrent Mild to

Moderate Clostridium Difficile Infection (CDI): A Prospective, Open–label, Randomized

Clinical Trial ACG 2010, San Antonio, TX; October 18-20

Effects of Orally Disintegrated Metoclopramide (ODM) in Optimizing Late Outpatient

Endoscopy: A Randomized Double-Blind Placebo-Controlled Clinical Trial ACG 2010, San

Antonio, TX; October 18-20

Effect of Melatonin in Functional Heart Burn- A Randomized Placebo Control Clinical Trial.

ACG 2010, San Antonio, TX; October 18-20

Interferon alfa Antibody (IFN alfa Ab) As A Useful Predictive Marker of Sustained Viral

Response (SVR) for Therapy in Chronic Hepatitis C

Hepatology International. 2010 Mar; 4(1): 201, Effect of High-Dose Ribavirin (RBV),

Alinia (Nitazoxanide) and Pegylated Interferon (PegIFN) alfa-2a in attaining Sustained

Virologic Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-C Trial) in Naïve

Genotype 1 Patients

Hepatology International. 2010 Mar; 4(1): 172, REtrospective Analysis of Pan

Asian Outcome of Response to Therapy for Hepatitis C - A Multicenter Study. REPORT-C

study – Columbia University, University of Hong Kong & PGI Chandigarh India,

Hepatology International. 2010 Mar; 4(1): 37, Transdermal Rivastigmine for Treatment

of Encephalopathy in Liver Cirrhosis - A Randomized Placebo Controlled Trial (TREC – trial)

Neurogastroenterology and Motility 2010. 2010 Aug; 22(S1, 23-90) 67, Role of

Melatonin In Colonic Motility in Irritable Bowel Syndrome – Constipation A Double blinded

randomized Placebo control clinical trial ( MIMI C )

Basu, K. Rayapudi, N.J. Shah, T. Pacana, N. Krishnaswamy, R. Brown Jr.. Effect of

High-dose Ribavirin (RBV), Alinia(Nitazoxanide)and Pegylated Interferon (PegIFN) ALFA-

2A in attaining Sustained Virologic Response (SVR) in Treatment of Chronic Hepatitis C

(ERAIS-C) in naive genotype 1 patients. Journal of Hepatology. 2010 Apr; 52(1): S102.

P. Basu, N.J. Shah, N. Krishnaswamy, H. Hampole, T. Pacana, K. Rayapudi, R. Brown

Jr.. Transdermal Rivastigmine for Treatment of Encephalopathy in Liver Cirrhosis. A

Randomized Placebo Controlled Trial (TREC Trial). Journal of Hepatology. 2010 Apr; 52(1):

S67-S68.

P. Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Nithya

Krishnaswamy, Chris Tang, Robert Brown Effect of high-dose ribavirin (RBV), alinia

(Nitazoxanide) and pegylated interferon (PegIFN) alfa-2a in attaining sustained virologic

response (SVR) in treatment of chronic hepatitis C (ERAIS-C Trial) in naïve genotype 1

patients. Accepted at DICID July 2010, Beijing, China, Published International Journal of

Infectious Diseases. 2010 Jul; 14(2): S1-S2.

P Patrick Basu, N James Shah, N V Krishnaswamy, R Korapati, and CC Tang Sequential use

of nitazoxanide (NTZ) as a salvage therapy in patient with recurrent mild to moderate

clostridium difficile infection (CDI): A prospective, open–label, randomized clinical trial.

Accepted at DICID July 2010, Beijing, China, Published International Journal of Infectious

Diseases.

P Patrick Basu, MD, N.V Krishnaswamy MD, R Korapati, MD, S Tammisetti MD, N James

Shah MD, H Hampole MD, Tommy Paccana MD, CC Tang MD. PhD. A new four-day

regimen with dexlansoprazole, moxifloxacin, amoxicillin, nitazoxanide, and doxycycline

(DeMAND) in helicobacter pylori therapy: an open-label randomized clinical trial. Accepted at

P Patrick Basu CV

15

DICID July 2010, Beijing, China, Published International Journal of Infectious Diseases 2010

Jul; 14(Supplement 2): S52.

Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Robert Brown Effect of

High-Dose Ribavirin (RBV), Alinia (Nitazoxanide) and Pegylated Interferon (PegIFN) alfa-2a

in attaining Sustained Virologic Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-

C Trial) in Naïve Genotype 1 Patients, APASL 2010, Beijing, March 2010

P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Robert Brown

REtrospective Analysis of Pan Asian Outcome of Response to Therapy for Hepatitis C - A

Multicenter Study. REPORT-C study – Columbia University, University of Hong Kong & PGI

Chandigarh India. APASL 2010, Beijing, March 2010


Transdermal Rivastigmine for Treatment of Encephalopathy in Liver Cirrhosis - A

Randomized Placebo Controlled Trial (TREC – trial ) , APASL 2010, Beijing, March 2010

P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Robert Brown Effect of

High-Dose Ribavirin (RBV), Alinia (Nitazoxanide) and Pegylated Interferon (PegIFN) alfa-2a

in attaining Sustained Virologic Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-

C Trial) in Naïve Genotype 1 Patients, EASL 2010



Randomized Placebo Controlled Trial (TREC – trial ) , EASL 2010

Gastroenterology Vol. 138, Issue 5, Supplement 1 , Page S-218, Effect of High-Dose Ribavirin

(RBV), Alinia (Nitazoxanide) and Pegylated Interferon (PegIFN) alfa-2a in attaining Sustained

Virologic Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-C Trial) in Naïve

Genotype 1 Patients,

Gastroenterology Vol. 138, Issue 5, Supplement 1 , Page S-368, Transdermal Rivastigmine

for Treatment of Encephalopathy in Liver Cirrhosis - A Randomized Placebo Controlled Trial

(TREC – trial ),

Gastroenterology Vol. 138, Issue 5, Supplement 1 , Page S-305, Assessment of Tissue Tumor

Necrosis factor alfa (TTNF–α) as a novel marker for latent Celiac disease,

Gastroenterology Vol. 138, Issue 5, Supplement 1 , Pages S-625-S-626, Intraepithelial CD3

and CD 4 as a unique surrogate marker for mucosal immunity in Irritable Bowel Syndrome

17TH

International meeting on hepatitis C and related virus, September 2010, page 148,

Abstract ID: 20401: Effect of High-Dose Ribavirin (RBV), Alinia (Nitazoxanide) and

Pegylated Interferon (PegIFN) alfa-2a in attaining Sustained Virologic Response (SVR) in

Treatment of Chronic Hepatitis C (ERAIS-C Trial) in Naive Genotype 1 Patients

17TH


Abstract ID: 20405: A Randomized Open Label Clinical Trial With Pregabalin in the

Treatment Regime With Interferon Therapy for Chronic Hepatitis C

17TH


Abstract ID: 20400: Interferon alfa Antibody (IFN alfa Ab) As A Useful Predictive Marker of

Sustained Viral Response (SVR) for Therapy in Chronic Hepatitis C

17TH


Abstract ID: 20404: A Retrospective Analysis of the Safety of Outpatient Percutaneous Liver

Biopsy in Patients with Von Willebrand Disease

P Patrick Basu CV

16

17TH


Abstract ID: 20406: Serum Retinol Binding Protein 4 (RBP-4) is a unique surrogate marker of

End stage Liver Disease with Complications. A Pilot clinical trial.

17TH


Abstract ID: 20402: Retrospective Analysis of Pan Asian Outcome of Response to Therapy for

Hepatitis C - A Multicenter Study (REPORT-C study)

Encephalopathy in Chronic Liver Failure, poster presentation done at EASL Monothematic

Conference on Portal Hypertension, Budapest, Hungary, January 2009

P Patrick Basu, Krishna Rayapudi, Jose Esteves, Robert Brown; A Retrospective Analysis of

the Safety of Outpatient Percutaneous Liver Biopsy in Patients with Von Willebrand Disease,

poster presentation done at EASL Monothematic Conference on Portal Hypertension,

Budapest, Hungary, January 2009

P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Syed Hussein, Sindhu Ramamurthy,

Robert Brown Jr; A Randomized Open Label Clinical Trial With Pregabalin in the Treatment

Regime with Interferon Therapy For Chronic Hepatitis C, accepted for poster presentation at

19th

APASL Conference, Hong Kong, February 2009

P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Syed Hussein, Sindhu Ramamurthy,

Robert Brown Jr; A Randomized Open Label Clinical trial with Oral Alfa Lipoic Acid and

Vitamin E in Non Alcoholic Fatty Liver disease, accepted for poster presentation at 3rd

International Congress on Prediabetes and the Metabolic Syndrome, Nice, France, April 2009

P Patrick Basu; Krishna Rayapudi; Tommy Pacana; Syed Hussein; Sindhu Ramamurthy;

Robert brown Jr; A Randomized Open label clinical trial with Pregabalin in the Treatment

Regimen with Interferon Alfa for Chronic Hepatitis C – accepted for poster presentation at

Asia Pacific Association for Study of Liver Disease Meeting , Hong Kong 13-16th

February

2009 and at the 13th

International Symposium on Viral hepatitis and Liver Disease,

Washington DC, March 20-24, 2009.

P Patrick Basu; Krishna Rayapudi; Tommy Pacana; Syed Hussein; Sindhu Ramamurthy;

Robert brown Jr; A Randomized Open label clinical trial with Pregabalin in the Treatment

Regimen with Interferon Alfa for Chronic Hepatitis C – accepted at Asia Pacific Association

for Study of Liver Disease Meeting , Hong Kong 13-16th

February 2009 and at the 13th

International Symposium on Viral hepatitis and Liver Disease, Washington DC, March 20-24,

2009

P Patrick Basu; Krishna Rayapudi; Tommy Pacana; Sindhu Ramamurthy; Robert brown Jr; A

randomized open label clinical trial with Alpha Lipoic acid and Vitamin E in Non-alcoholic

fatty liver disease – accepted at Asia Pacific Association for Study of Liver Disease Meeting ,

Hong Kong February 13-16, 2009 and at Digestive Disease Week 2009, Chicago

Basu, P Patrick; Dinani, Amreen; Rayapudi, Krishna; Pacana, Tommy; Ramamurthy, Sindhu;

Rifaximin Salvage therapy for Metronidazole resistant Clostridium difficile Colitis - A

Prospective Pilot Trial – Accepted at Digestive Disease Week 2009, Chicago

Basu, P Patrick; Rayapudi, Krishna; Pacana, Tommy; Ramamurthy, Sindhu; Prevalence of

Restless Leg Syndrome in patients with functional bowel disease in the community - accepted

as a poster presentation at the 2009 Neurogastroenterology and Motility Joint International

meeting to be held August 27-30, 2009 in Chicago, Illinois


randomized open label clinical trial with Alpha Lipoic acid and Vitamin E in Non-alcoholic

fatty liver disease - selected for poster presentation at the EASL Special Conference on

P Patrick Basu CV

17

NAFLD/NASH and Related Metabolic Disease, taking place in Bologna, Italy, September 24-

26, 2009



Prospective Pilot Trial –Accepted for poster presentation at the Third Ditan International

Conference on Infectious Diseases to be held at Beijing, China from 30 July - 2 Aug , 2009

P Patrick Basu, Krishna Rayapudi, Vincent W. Wong, Kenneth Yan, Niraj James Shah,

Tommy Pacana, Robert S. Brown; Retrospective Analysis of Pan Asian Outcome of Response

to Therapy for Hepatitis C - A Multicenter Study- REPORT-C study – accepted for poster

presentation at AASLD 2009, Boston, MA



Prospective Pilot Trial – Accepted for poster presentation at The American College of

Gastroenterology Meeting, San Diego, CA to be held from 23-28 October 2009

P Patrick Basu, Krishna Rayapudi, Vincent Wong, Kenneth Yan, Tommy Pacana, Niraj James

Shah, Robert Brown; Retrospective Analysis of Pan Asian Outcome of Response to Therapy

for Hepatitis C - A Multicenter Study (REPORT-C study) – Interim Results- Accepted for

poster presentation at The American College of Gastroenterology Meeting, San Diego, CA to

be held from 23-28 October 2009

P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah, Robert Brown; Effects

of High Dose Ribavirin, Alinia (Nitazoxanide) and Pegylated Interferon alfa-2a in Attaining

Sustained Viral Response in Treatment of Chronic Hepatitis C (ERAIS-C trial) - Interim

Results in Naïve Genotype 1 Patients- Accepted for poster presentation at The American

College of Gastroenterology Meeting, San Diego, CA to be held from 23-28 October 2009

P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Niraj James Shah; Prevalence of Restless

Leg Syndrome in Patients With Functional Bowel Disease in the Community- Accepted for

poster presentation at The American College of Gastroenterology Meeting, San Diego, CA to

be held from 23-28 October 2009

P Patrick Basu, Niraj James Shah, Krishna Rayapudi, Tommy Pacana, Naveen P.

Narayankutty, Sherry Taylor; Intraepithelial CD3+ and CD4+ Cells as Unique Surrogate

Markers for Mucosal Immunity in Irritable Bowel Syndrome- Accepted for poster presentation

at The American College of Gastroenterology Meeting, San Diego, CA to be held from 23-28

October 2009

P Patrick Basu, Krishna Rayapudi, Tommy Pacana, Syed Hussain, Niraj James Shah, Robert

Brown; A Randomized Open Label Clinical Trial With Pregabalin In The Treatment Regime

With Interferon Therapy For Chronic Hepatitis C - Accepted for poster presentation at The

American College of Gastroenterology Meeting, San Diego, CA to be held from 23-28 October

2009

Basu, P Patrick; Rayapudi, Krishna; Estevez, Jose; A Randomized Double Blinded Clinical

Trial with Omeprazole, Levofloxacin and Escalated Dose of Rifaximin for Helicobacter Pylori

in Treatment-Naïve Population, Gastroenterology, April 2008;134, No. 4, Suppl. 1:A-336,

presented as poster at Digestive Disease Week Meeting 2008, San Diego, California

Basu, P Patrick; Rayapudi, Krishna; Robert Brown Jr MD; A Retrospective Analysis of the

Safety of Outpatient Percutaneous Liver Biopsies with Von Willebrand Disease, Hepatology

International, June 2008; 2, Suppl. 2:S131-132, presented as poster at International Liver

Congress Meeting 2008, Hong Kong, China

P Patrick Basu CV

18

PP Basu, K Rayapudi, J Esteves, R Brown Jr; A Pilot Study Utilizing Nitazoxanide for Hepatic

Encephalopathy in Chronic Liver Failure, Journal of Gastroenterology and Hepatology 2008;

23, Suppl. 5: A 49, presented as poster at Asia Pacific Digestive Week Meeting 2008, New

Delhi, India

PP Basu, K Rayapudi, R Brown Jr ; A Retrospective Analysis of the Safety of Outpatient

Percutaneous Liver Biopsies with Von Willebrand Disease, Journal of Gastroenterology and

Hepatology, September 2008; 23, Suppl. 5: A 49, presented as poster at Asia Pacific Digestive

Week Meeting 2008, New Delhi, India

PP Basu, K Rayapudi, J Esteves; LEND (Levaquin, Esomeprazole, Nitazoxanide and

Doxycycline) for the treatment of previously Non-Responsive Helicobacter pylori, Journal of

Gastroenterology and Hepatology, September 2008; 23, Suppl. 5: A 119, presented as poster at

Asia Pacific Digestive Week Meeting 2008, New Delhi, India

PP Basu, K Rayapudi, J Esteves; A Randomized Double Blinded Clinical Trial with

Omeprazole, Levofloxacin and Escalated Dose of Rifaximin for Helicobacter Pylori in

Treatment-Naïve Population, Journal of Gastroenterology and Hepatology, September 2008;

23, Suppl. 5: A 119, presented as poster at Asia Pacific Digestive Week Meeting 2008, New

Delhi, India

P Basu, K Rayapudi, J Esteves, T Crook; Mucosal Mastocytosis as a Histological Marker in

Diarrhea Predominant Irritable Bowel Syndrome, Journal of Gastroenterology and Hepatology

2008; 23, Suppl. 5: A 11

P Patrick Basu, Krishna Rayapudi, Jose Esteves; LEND (Levofloxacin, Esomeprazole,

Nitazoxanide and

Doxycycline) for the Treatment of previously Non-Responsive Helicobacter pylori, The

American Journal of Gastroenterology September 2008; 103, S1: pages S52-53 ; poster

presentation done at American College of Gastroenterology Meeting 2008, Orlando, Florida



The American Journal of Gastroenterology September 2008; 103, S1: page S164-165 ; poster

presentation done at American College of Gastroenterology Meeting 2008, Orlando, Florida

P Patrick Basu, Krishna Rayapudi, Jose Esteves, Terri Crook; Mucosal Mastocytosis as a

Histological Marker in Diarrhea Predominant Irritable Bowel Syndrome, The American

Journal of Gastroenterology September 2008; 103, S1: page S474; poster presentation done at

American College of Gastroenterology Meeting 2008, Orlando, Florida

P Patrick Basu, Krishna Rayapudi, Jose Esteves, Robert Brown; A Pilot Study Utilizing

Nitazoxanide for Hepatic Encephalopathy in Chronic Liver Failure, The American Journal of

Gastroenterology September 2008; 103, S1: page S151; poster presentation done at American

College of Gastroenterology Meeting 2008, Orlando, Florida

P Patrick Basu, Krishna Rayapudi, Jose Esteves; Novel Therapy for the Non-responder

population with H pylori - LEND (Levofloxacin, Esomeprazole, Nitazoxanide and

Doxycycline) Study; Gut October 2008; 57, Supplement 2: page A328; poster presentation

done at United European Gastroenterology Week October 2008, Vienna, Austria



Gut October 2008; 57, Supplement 2: page A387; poster presentation done at United European

Gastroenterology Week October 2008, Vienna, Austria

P Patrick Basu CV

19

Basu, P Patrick; Rayapudi, Krishna; Estevez, Jose; A Randomized Double Blinded Clinical

Trial with Omeprazole, Levofloxacin and Escalated Dose of Rifaximin for Helicobacter Pylori

in Treatment-Naïve Population, Gut October 2008; 57 Supplement 2: page A 328; poster

presentation done at United European Gastroenterology Week October 2008, Vienna, Austria


Nitazoxanide for Hepatic Encephalopathy in Chronic Liver Failure, Gut October 2008; 57

Supplement 2: page A 21


Nitazoxanide for Hepatic Encephalopathy in Chronic Liver Failure, Hepatology October

2008;48 Number4: pages 1085A-1086A; poster presentation done at American association for

the Study of Liver Disease Meeting, October-November 2008, SanFrancisco, California

P Patrick Basu, Krishna Rayapudi, Jose Esteves, Terri Crook; Mucosal Mastocytosis as a

Histological Marker in Diarrhea Predominant Irritable Bowel Syndrome,

Neurogastroenterology and Motility, November 2008; 20 supplement 2: page 69; poster

presentation done at Neurogastroenetrology and Motility Joint International Meeting,

November 2008 Lucerne, Switzerland


Nitazoxanide for Hepatic

―Argon Plasma Coagulation with 1% Alum Irrigation Reduces Re-bleeding

Associated with Radiation Proctitis―;Kaumudi Somnay, Ellen Gutkin, Ratesh Khillan, P.

Patrick Basu, Natalya Belova, Raj Wadgaonkar, Dattatreyudu Nori; accepted for DDW May

2008, San Diego, California

―A Novel Therapy With Rifixamine, Omeprazole & Levofloxacine for H pylori

Therapy in Naive Patients‖; American College of Gastroenterology, Las Vegas, NV , 10/2006

―Argon Plasma Coagulation with 1% Alum Irrigation Reduces Re-bleeding

Associated with Radiation Proctitis―; Kaumudi Somnay, Ellen Gutkin, Ratesh Khillan, P.

Patrick Basu, Natalya Belova, Raj Wadgaonkar, Dattatreyudu Nori; accepted for DDW May

2008, San Diego, California

Index and Reviews – Hepatitis – March 2004

―Giant Cell Hepatitis With Super Imposed Autoimmune Hepatitis.‖; American College of

Gastroenterology, Las Vegas 2001

―Effectiveness of High Dose Hepatitis B Vaccine in Alcoholic Patients, a randomized Placebo

Controlled Trial‖; May 1995 – American Gastroenterology Assoc. (AGA), San Diego, CA

―Utility of Carbohydrate-Deficient Transferrin as a Marker of Relapse in Alcoholic Patients.

June 1994 - Annual Meeting, Research Alcohol Assoc. (RSA), Maui, Hawaii

August 1994 - Mt. Sinai Medical Center Research Day, New York, NY

Oral Presentations

Digestive Disease Week 2011May 7-10, in Chicago, Illinois, Interferon alfa Antibody

(IFN alfa Ab) As A Useful Predictive Marker of Sustained Viral Response (SVR) for Therapy

in Chronic Hepatitis C

Digestive Disease Week 2011 May 7-10, in Chicago, Illinois, Effect of Melatonin in

Functional Heart Burn- A Randomized Placebo-Controlled Clinical Trial

P Patrick Basu CV

20

4th International Congress on Prediabetes and the Metabolic Syndrome in Madrid,

Spain, April 6-9, 2011. Effect of Vitamin E and Alfa Lipoic Acid In Non-alcoholic fatty liver

disease: A randomize placebo control prospective clinical Trial-V A I N Trial


Montaser, MD, Chris Tang, MD, PhD and Robert Brown, MD Transdermal Rivastigmine for

Treatment of Encephalopathy in Liver Cirrhosis - A Randomized Placebo Controlled Trial

(TREC trial ). June 2011, ILTS. In Press-

2011 Joint International Congress of ILTS (International Liver Transplantation

Society), ELITA (The European Liver and Intestine Transplant Association) , & LICAGE (The

Liver Intensive Care Group of Europe), June 22-25, 2011, in Valencia, Spain. Transdermal

Rivastigmine for Treatment of Encephalopathy in Liver Cirrhosis - A Randomized Placebo

Controlled Trial (TREC - Trial).

2010 Neurogastroenterology and Motility Joint International meeting, Chicago, Illinois ,

Role of Melatonin In Colonic Motility in Irritable Bowel Syndrome – Constipation A Double

Blinded Randomized Placebo control clinical trial (MIMI C )

DICID 2010, Beijing 2010, OL-008: Sequential use of nitazoxanide (NTZ) as a salvage

therapy in patient with recurrent mild to moderate clostridium difficile infection (CDI): A

prospective, open–label, randomized clinical trial

DICID 2010, Beijing 2010, Effect of High-Dose Ribavirin (RBV), Alinia

(Nitazoxanide) and Pegylated Interferon (PegIFN) alfa-2a in attaining Sustained Virologic

Response (SVR) in Treatment of Chronic Hepatitis C (ERAIS-C Trial) in Naive Genotype 1

Patients



Randomized Placebo Controlled Trial (TREC – trial ) , APASL 2010, Beijing, March 2010


randomized open label clinical trial with Alpha lipoic acid and Vitamin E in Non-alcoholic

fatty liver disease – Accepted for oral presentation The American College of Gastroenterology

Meeting, San Diego, CA to be held from 23-28 October 2009.

Basu, P Patrick; Rayapudi, Krishna; Pacana, Tommy; Ramamurthy, Sindhu; A Randomized

Open-label Clinical Trial with Levofloxacin, Omeprazole, Alinia (Nitazoxanide), and

Doxycycline (LOAD) versus Lansoprazole, Amoxicillin and Clarithromycin (LAC) in the

treatment naive Helicobacter pylori population – accepted for Oral presentation at President’s

plenary session of The American College of Gastroenterology Meeting, San Diego, CA to be

held from 23-28 October 2009.




treatment naive Helicobacter pylori population – Oral presentation done by T Pacana at Third

Ditan International Conference on Infectious Diseases held at Beijing, China from 30 July - 2

Aug , 2009




treatment naive Helicobacter pylori population – Oral presentation done by P Basu at

Digestive Disease Week – May 2009,Chicago

P Patrick Basu CV

21


randomized open label clinical trial with Alpha lipoic acid and Vitamin E in Non-alcoholic

fatty liver disease – Oral presentation done by P Basu at Asia Pacific Association for Study of

Liver Disease Meeting , Hong Kong February 13-16, 2009


Nitazoxanide for Hepatic Encephalopathy in Chronic Liver Failure, Oral presentation done by

K Rayapudi at United European Gastroenterology Week, October 2008, Vienna, Austria

P Basu, K Rayapudi, J Esteves, T Crook; Mucosal Mastocytosis as a Histological Marker in

Diarrhea Predominant Irritable Bowel Syndrome, Oral Presentation done by K Rayapudi at

Asia Pacific Digestive Week Meeting, September 2008, New Delhi, India

Grand Round Lectures

Chronic Constipation; Peninsula General Hospital, NY March 2nd

2011 ,

Recent Updates on Hepatitis C Virus; March 2, 2011; North Shore LIJ- Manhasset;

Manhasset, NY

Recent Updates on Helicobacter Pylori; February 23, 2011; North Shore LIJ-Forest Hills,

Forest Hills, NY

Fatty Liver; December 14, 2010; All India Institute of Medical Sciences (AIIMS), India

Hepatitis C; December 26-28, 2010 ; Botanicals in Integrated Health Care, India

Fatty Liver; Indian Postgraduate Medical Education and Research (IPGMER), India Dec 26th

2010 .

Long-Term Considerations in Chronic Hepatitis B (CHB); May 12, 2010, New York Methodist

Hospital, Brooklyn, NY

Fatty Liver Disease, April 28, 2010, Columbia Presbetarian Hospital

Cirrhosis of liver and its complications

Jan 13, 2010, North Shore university hospital Forest hills

Helicobactor Pylori recent update 2010

Jan 24, 2010 – N Y Hospital Queens

NAFLD/NASH

August 18, 2009 – Fellows Grand Round Lecture, NSLIJ Hospital

Cirrhosis of liver and its complications ; April 2009 Medical grand rounds NY hospital of

queens NY

Cirrhosis and its Complications

March 3, 2009 – Fellows Grand round Lecture, NSLIJ Hospital

Iron Overload and Hemochomatosis

Jan 7, 2009 - Forest Hills Hospital

Evidenced based evaluation of liver function tests

Dec 9th 2008 - NY Hospital Queens

Update on Hepatitis B

November 2008 - SUNY Down State, New York

Non Alcoholic Steato Hepatitis

October 2008 - Brooklyn Hospital NY

Hepatitis B - Recent Update

P Patrick Basu CV

22

October 24, 2008 - GI Grand Rounds - SUNY Downstate Medical Center

Biologics in IBD

October 22, 2008 - GI Grand Rounds - New York Hospital Queens

New Horizons in Hepatitis C Treatment

October 14, 2008 – Medical Grand Rounds - New York Hospital Queens

Controversies and Future Management of Chronic Hepatitis-C

July 21, 2008 – Grand Rounds – St. Vincent’s Hospital New York, NY

Iron Homeostasis and Hemochromatosis

April 11, 2008 – Grand Rounds - Methodist Hospital, Brooklyn, New York

Fatty Liver Disease

March 28, 2008 – Grand Rounds - Mt.Sinai School of Medicine, New York, NY


March 7th 2008 – Grand Rounds - Brookdale Hospital, Brooklyn, New York


February 27th 2008 – Grand Rounds - New York Hospital, Queens, New York

Recent Advances in Hepatitis B

Jan 30th 2008 – Grand Rounds North Shore University Hospital at Forest Hills

Recent Updates on Chronic Hepatitis B

December 2007 – G/I Grand Rounds – Brooklyn Hospital, Brooklyn, NY

Alcohol, Alcoholism and Alcohol Related Liver Disease

December 2007 – G/I Grand Rounds - NY Hospital Queens, Queens, NY

Acute Liver Failure

December 2007 – Medical Grand Rounds - Bronx VA Medical Center, Bronx, NY

Hepatitis-C Recent Update

March 2007 – Medical Grand Rounds – Peninsula General Hospital,Brooklyn, NY

Acute Liver Failure

March 2007 – Medical Grand Rounds –New York Hospital Queens

Chronic Hepatitis

January 2007 – Medical Grand Rounds – Brookdale Hospital, Brooklyn, NY

Acute Liver Failure

January 2007 – Medical Grand Rounds – North Shore University Hospital at Forest Hills

Fatty Liver Disease

August 2006 – Medical Grand Rounds – Brookdale Hospital, Brooklyn, NY

Fatty Liver Disease

July 2006 – Medical Grand Rounds – New York Hospital Queens

New Horizons in Chronic Hepatitis C

May 2006 – Medical Grand Rounds – New Parkway Hospital at Forest Hills

Fatty Liver and NASH

May 2006 – St. Vincent’s Hospital, Staten Island, NY

Alcohol Related Liver Disease

February 2006 – G/I Grand Rounds – Columbia-Presbyterian Medical Ctr.

Fatty Liver And Its Recent Management.

December 2005 - G/I Grand Rounds - NYHQ

New Insight On Future Management Of Hepatitis C.

September 2005 - North Shore University Hospital Forest Hills.

P Patrick Basu CV

23

Caribbean Symposium On Gastroenterology And Hepatology

1. Management Of G E R D And Its Complication.

2. Alcohol And Alcoholic Liver Disease.

October 2005 - Dominican Republic @ Porto Platta

Recent Advances And Management Of Portal Hypertension

November 2005 – G/I Grand Round - NY Methodist Hospital, Brooklyn, NY

Alcohol And Alcoholic Liver Disease at

September 2005 - Grand Round - New Parkway Hospital at Forest Hills

Portal Hypertension in the 21st Century

May 2005 - G/I Grand Rounds - Maimonedes Medical Center

Portal Hypertension in the 21st Century

April 2005 – G/I Grand Rounds - NYHQ

Alcohol And Alcohol Related Liver Disease.

January 2005 - Medical Grand Rounds – NYHQ

Primary Biliary Cirrhosis

September 2004 – G/I Grand Rounds – Westchester Medical Center

Primary Biliary Cirrhosis

June 2004 – Medical Grand Rounds – NSUHFH

Acute Liver Failure.

June 2004 – G/I Grand Rounds – Westchester Medical Center.

Treatment of Anemia in Chronic HCV on Interferon

02/18/02 – CME Grand Round – North Shore University Hospital at F.H.

New Treatment of Chronic Hepatitis B

10/2001 – Lenox Hill Hospital, New York, NY

Endoscopic Ultrasound – A Novel Modality in the New Millennium‖

1999 – All India Institute of Medical Science and Research, India

―Hepatitis C – A Silent Killer‖

1999 – Calcutta Medical Center and Research, Calcutta, India

―Recent Update on Hepatic Encephalopathy‖

1996 - Elmhurst General Hospital, Elmhurst, NY

1995 - La Guardia Hospital, Forest Hills, NY

1994 - Neurology Grand Round, Mt. Sinai Medical Center, New York, NY

―Hemachromatosis‖

1996 - North Shore University Hospital of Forest Hills, Forest Hills, NY

1996 - Bronx V.A. Medical Center, Bronx, NY

―Recent Update on Viral Hepatitis‖

1993 -New York Downtown Hospital, New York, NY

―Hepatocellular Carcinoma‖

1992 -New York Downtown Hospital, New York, NY

Miscellaneous

Advisory Board Member

P Patrick Basu CV

24

American Liver Foundation – NY Chapter

Gilead Sciences

Vertex HCV Professional Speaker Bureau

National Speaker for:

Gilead

Roche

Salix

Takada

UCB

Abbott

Three rivers

Santoris

Axcan

Schering Plough

Astra Zeneca

TAP

Bristol Myers

Novartis

References

Emmet B Keeffe MD

Emeritus Professor of Medicine

Former President of AGA and AASLD

Former Chief of Hepatology at Stanford University


Robert S. Brown, Jr., MD, MPH

Frank Cardile Professor of Medicine and Surgery

Chief, Center for Liver Disease and Transplantation

Columbia University College of Physicians & Surgeons

New York Presbyterian, 622 West 168 Street, PH 14, New York, NY 10032

Phone: (212) 305-0662

Fax: (212) 305-9139


Ira M. Jacobson, MD

Chief, Division of Gastroenterology and Hepatology

Vincent Astor Distinguished Professor of Clinical Medicine

Cornell University/New York Presbyterian Hospital, New York, NY

Arun Sanyal, MD

Professor of Medicine

Division chief dept of medicine and gastroenterology

mailto:[email protected]

P Patrick Basu CV

25

Virginia Common wealth university , Richmond VA


Maurice Cerrulli, MD

Program Director, Gastroenterology Training Program

North Shore LIJ Hospital


----------------------------------------------------------

curriculum vitae p patrick basu, md, mrcp, agaf

Documents